BR9810623B1 - processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto. - Google Patents

processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto.

Info

Publication number: BR9810623B1
Authority: BR; Brazil
Prior art keywords: salt; enantiomers; compound; preparation; growth hormone
Prior art date: 1997-06-25

Application number

BRPI9810623-6A

Other languages

English (en)

Other versions

BR9810623A (pt

Inventor

Philip Albert Carpino

Paul Andrew Dasilva-Jardine

Bruce Allen Lefker

Jerry Anthony Murry

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-25

Filing date

1998-06-05

Publication date

2010-06-15

1998-06-05 Application filed filed Critical

2000-07-25 Publication of BR9810623A publication Critical patent/BR9810623A/pt

2010-06-15 Publication of BR9810623B1 publication Critical patent/BR9810623B1/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Immunology (AREA)
Crystallography & Structural Chemistry (AREA)
Neurology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)

BRPI9810623-6A 1997-06-25 1998-06-05 processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto. BR9810623B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5072397P	1997-06-25	1997-06-25
PCT/IB1998/000874 WO1998058948A1 (en)	1997-06-25	1998-06-05	Tartrate salt of a substituted dipeptide as growth hormone secretagogue

Publications (2)

Publication Number	Publication Date
BR9810623A BR9810623A (pt)	2000-07-25
BR9810623B1 true BR9810623B1 (pt)	2010-06-15

Family

ID=21966996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9810623-6A BR9810623B1 (pt)	1997-06-25	1998-06-05	processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto.

Country Status (40)

Country	Link
US (2)	US6248717B1 (pt)
EP (1)	EP0989993B1 (pt)
JP (1)	JP3414759B2 (pt)
KR (1)	KR100339936B1 (pt)
CN (2)	CN1524857A (pt)
AP (1)	AP1043A (pt)
AR (1)	AR012255A1 (pt)
AT (1)	ATE388163T1 (pt)
AU (1)	AU744775B2 (pt)
BG (1)	BG104024A (pt)
BR (1)	BR9810623B1 (pt)
CA (1)	CA2294422C (pt)
CO (1)	CO4810383A1 (pt)
DE (1)	DE69839211T2 (pt)
DK (1)	DK0989993T3 (pt)
DZ (1)	DZ2538A1 (pt)
EA (1)	EA002643B1 (pt)
ES (1)	ES2301196T3 (pt)
GT (1)	GT199800085A (pt)
HR (1)	HRP980362A2 (pt)
HU (1)	HUP0002664A3 (pt)
ID (1)	ID23188A (pt)
IL (1)	IL132810A0 (pt)
IS (1)	IS5276A (pt)
MA (1)	MA26516A1 (pt)
NO (1)	NO996469L (pt)
NZ (1)	NZ500658A (pt)
OA (1)	OA11241A (pt)
PA (1)	PA8453401A1 (pt)
PE (1)	PE97599A1 (pt)
PL (1)	PL337654A1 (pt)
PT (1)	PT989993E (pt)
SK (1)	SK177299A3 (pt)
TN (1)	TNSN98111A1 (pt)
TR (1)	TR199903261T2 (pt)
TW (1)	TWI221153B (pt)
UA (1)	UA53716C2 (pt)
UY (1)	UY25059A1 (pt)
WO (1)	WO1998058948A1 (pt)
ZA (1)	ZA985541B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
US6465445B1 (en)	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6380184B1 (en)	1998-10-28	2002-04-30	Bristol-Myers Squibb Co.	Benzoazepines and analogs thereof useful as growth hormone secretagogues
AU759022B2 (en)	1999-02-18	2003-04-03	Kaken Pharmaceutical Co., Ltd.	Novel amide derivatives as growth hormone secretagogues
US6541634B2 (en)	1999-02-26	2003-04-01	Pfizer Inc.	Process for preparing growth hormone secretagogues
US6525203B1 (en)	1999-03-12	2003-02-25	Bristol-Myers Squibb Company	Heterocyclic aromatic compounds useful as growth hormone secretagogues
US6518292B1 (en)	1999-03-12	2003-02-11	Bristol-Myers Squibb Co.	Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US20020013327A1 (en) *	2000-04-18	2002-01-31	Lee Andrew G.	Compositions and methods for treating female sexual dysfunction
AU5959201A (en)	2000-05-11	2001-11-20	Bristol Myers Squibb Co	Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
EP1289526A4 (en)	2000-05-30	2005-03-16	Merck & Co Inc	MELANOCORTIN RECEPTOR AGONISTS
ES2333097T3 (es) *	2000-05-31	2010-02-17	Raqualia Pharma Inc	Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
IL143690A0 (en) *	2000-06-19	2002-04-21	Pfizer Prod Inc	The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
IL143942A0 (en) *	2000-06-29	2002-04-21	Pfizer Prod Inc	Use of growth hormone secretagogues for treatment of physical performance decline
EP1181933A3 (en) *	2000-06-29	2002-04-10	Pfizer Products Inc.	Use of growth hormone secretagogues for stimulating or increasing appetite
EP1313473A2 (en) *	2000-08-30	2003-05-28	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
EP1192943A3 (en) *	2000-09-28	2002-11-27	Pfizer Products Inc.	Use of growth hormone secretagogues in conjunction with physical exercise
PT1326851E (pt) *	2000-10-13	2004-11-30	Lilly Co Eli	Dipeptidos substituidos como secretagogues da hormona do crescimento
CA2372450A1 (en) *	2001-05-10	2001-09-19	Pharmaceutical Partners Of Canada Inc.	Liquid injectable formulation of disodium pamidronate
US7125840B2 (en)	2001-10-09	2006-10-24	Eli Lilly And Company	Substituted dipeptides as growth hormone secretagogues
US6649606B1 (en)	2001-11-09	2003-11-18	Bristol-Myers Squibb Co.	Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
WO2003087069A2 (en)	2002-04-09	2003-10-23	Eli Lilly And Company	Dipeptidic growth hormone secretagogues
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2005027913A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
WO2005097788A2 (en) *	2004-04-02	2005-10-20	Elixir Pharmaceuticals, Inc.	Sulfonamides and uses thereof
KR100641571B1 (ko) *	2005-01-05	2006-10-31	주식회사 팬택앤큐리텔	이동통신 단말기에서의 클럭 발생 장치
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
KR20090107088A (ko)	2007-02-09	2009-10-12	트랜자임 파르마 인크	거대고리 그렐린 수용체 조절제 및 이의 사용 방법
US8377863B2 (en)	2007-05-29	2013-02-19	Unigene Laboratories Inc.	Peptide pharmaceutical for oral delivery
WO2012171987A1 (en) *	2011-06-16	2012-12-20	Lonza Ltd	A process for extraction of peptides and its application in liquid phase peptide synthesis
US9949992B2 (en) *	2011-11-16	2018-04-24	Duke University	Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
US9119832B2 (en)	2014-02-05	2015-09-01	The Regents Of The University Of California	Methods of treating mild brain injury
US9833411B2 (en)	2015-01-12	2017-12-05	Enteris Biopharma, Inc.	Solid oral dosage forms
WO2017075535A1 (en)	2015-10-28	2017-05-04	Oxeia Biopharmaceuticals, Inc.	Methods of treating neurodegenerative conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4411890A (en)	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
JPH08503213A (ja)	1992-11-06	1996-04-09	メルクエンドカンパニーインコーポレーテッド	成長ホルモンの放出を促進する置換ジペプチド同族体
PL176993B1 (pl)	1992-12-11	1999-08-31	Merck & Co Inc	Nowe związki spiropiperydynowe oraz sposób ich wytwarzania
EP0739204A4 (en) *	1993-11-09	2000-03-15	Merck & Co Inc	PIPERIDINE, PYRROLIDINE AND HEXAHYDRO-1H-AZEPINE SUPPORT THE RELEASE OF THE GROWTH HORMONE
TW432073B (en)	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
GT199800127A (es)	1997-08-29	2000-02-01		Combinaciones terapeuticas.

1998
- 1998-05-06 UA UA99127067A patent/UA53716C2/uk unknown
- 1998-06-05 JP JP50402799A patent/JP3414759B2/ja not_active Expired - Fee Related
- 1998-06-05 DE DE69839211T patent/DE69839211T2/de not_active Expired - Lifetime
- 1998-06-05 ID IDW991663A patent/ID23188A/id unknown
- 1998-06-05 KR KR1019997012222A patent/KR100339936B1/ko not_active IP Right Cessation
- 1998-06-05 WO PCT/IB1998/000874 patent/WO1998058948A1/en active IP Right Grant
- 1998-06-05 AT AT98921681T patent/ATE388163T1/de not_active IP Right Cessation
- 1998-06-05 NZ NZ500658A patent/NZ500658A/en unknown
- 1998-06-05 IL IL13281098A patent/IL132810A0/xx unknown
- 1998-06-05 EP EP98921681A patent/EP0989993B1/en not_active Expired - Lifetime
- 1998-06-05 BR BRPI9810623-6A patent/BR9810623B1/pt not_active IP Right Cessation
- 1998-06-05 PT PT98921681T patent/PT989993E/pt unknown
- 1998-06-05 SK SK1772-99A patent/SK177299A3/sk unknown
- 1998-06-05 US US09/380,886 patent/US6248717B1/en not_active Expired - Lifetime
- 1998-06-05 ES ES98921681T patent/ES2301196T3/es not_active Expired - Lifetime
- 1998-06-05 CN CNA2004100059410A patent/CN1524857A/zh active Pending
- 1998-06-05 TR TR1999/03261T patent/TR199903261T2/xx unknown
- 1998-06-05 EA EA199901076A patent/EA002643B1/ru not_active IP Right Cessation
- 1998-06-05 CN CN98806559A patent/CN1314912A/zh active Pending
- 1998-06-05 PL PL98337654A patent/PL337654A1/xx unknown
- 1998-06-05 DK DK98921681T patent/DK0989993T3/da active
- 1998-06-05 CA CA002294422A patent/CA2294422C/en not_active Expired - Lifetime
- 1998-06-05 AU AU74455/98A patent/AU744775B2/en not_active Ceased
- 1998-06-05 HU HU0002664A patent/HUP0002664A3/hu unknown
- 1998-06-11 PA PA19988453401A patent/PA8453401A1/es unknown
- 1998-06-18 GT GT199800085A patent/GT199800085A/es unknown
- 1998-06-18 AP APAP/P/1998/001266A patent/AP1043A/en active
- 1998-06-19 PE PE1998000540A patent/PE97599A1/es not_active Application Discontinuation
- 1998-06-22 TW TW087110024A patent/TWI221153B/zh not_active IP Right Cessation
- 1998-06-23 AR ARP980103022A patent/AR012255A1/es not_active Application Discontinuation
- 1998-06-23 UY UY25059A patent/UY25059A1/es not_active IP Right Cessation
- 1998-06-24 MA MA25138A patent/MA26516A1/fr unknown
- 1998-06-24 DZ DZ980148A patent/DZ2538A1/xx active
- 1998-06-24 TN TNTNSN98111A patent/TNSN98111A1/fr unknown
- 1998-06-25 ZA ZA9805541A patent/ZA985541B/xx unknown
- 1998-06-25 CO CO98036378A patent/CO4810383A1/es unknown
- 1998-06-25 HR HR60/050,723A patent/HRP980362A2/hr not_active Application Discontinuation
1999
- 1999-11-26 IS IS5276A patent/IS5276A/is unknown
- 1999-12-16 BG BG104024A patent/BG104024A/bg unknown
- 1999-12-21 OA OA9900299A patent/OA11241A/en unknown
- 1999-12-23 NO NO996469A patent/NO996469L/no not_active Application Discontinuation
2000
- 2000-12-11 US US09/734,269 patent/US6596867B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK0989993T3 (da)	2008-06-02
UA53716C2 (uk)	2003-02-17
PT989993E (pt)	2008-04-15
MA26516A1 (fr)	2004-12-20
PE97599A1 (es)	1999-10-12
AP9801266A0 (en)	1998-06-30
AU7445598A (en)	1999-01-04
CN1314912A (zh)	2001-09-26
IS5276A (is)	1999-11-26
AU744775B2 (en)	2002-03-07
EP0989993B1 (en)	2008-03-05
SK177299A3 (en)	2001-09-11
IL132810A0 (en)	2001-03-19
US6596867B2 (en)	2003-07-22
PL337654A1 (en)	2000-08-28
PA8453401A1 (es)	2000-05-24
OA11241A (en)	2003-05-26
EP0989993A1 (en)	2000-04-05
HUP0002664A3 (en)	2001-12-28
AR012255A1 (es)	2000-09-27
BG104024A (bg)	2000-07-31
UY25059A1 (es)	2000-12-29
TR199903261T2 (xx)	2000-08-21
DE69839211T2 (de)	2009-03-19
JP2000514840A (ja)	2000-11-07
US6248717B1 (en)	2001-06-19
HRP980362A2 (en)	1999-02-28
ZA985541B (en)	2000-01-10
GT199800085A (es)	1999-12-10
EA199901076A1 (ru)	2000-08-28
CA2294422C (en)	2003-07-22
CA2294422A1 (en)	1998-12-30
CO4810383A1 (es)	1999-06-30
TNSN98111A1 (fr)	2005-03-15
NO996469L (no)	2000-02-23
JP3414759B2 (ja)	2003-06-09
KR20010014153A (ko)	2001-02-26
CN1524857A (zh)	2004-09-01
HUP0002664A2 (hu)	2000-12-28
TWI221153B (en)	2004-09-21
AP1043A (en)	2002-02-04
ID23188A (id)	2000-03-23
ATE388163T1 (de)	2008-03-15
KR100339936B1 (ko)	2002-06-10
NZ500658A (en)	2001-08-31
US20010016570A1 (en)	2001-08-23
EA002643B1 (ru)	2002-08-29
BR9810623A (pt)	2000-07-25
ES2301196T3 (es)	2008-06-16
DZ2538A1 (fr)	2003-02-08
DE69839211D1 (de)	2008-04-17
NO996469D0 (no)	1999-12-23
WO1998058948A1 (en)	1998-12-30

Legal Events

Date	Code	Title	Description
2007-08-07	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2009-09-22	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-06-15	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/06/2010, OBSERVADAS AS CONDICOES LEGAIS.
2011-04-19	B25A	Requested transfer of rights approved	Owner name: RAQUALIA PHARMA INC. (JP) Free format text: TRANSFERIDO DE: PFIZER PRODUCTS INC.
2018-04-03	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
2018-07-24	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BR9810623B1 (pt)	2010-06-15	processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto.
BR9606040A (pt)	1998-08-25	Processo para a preparação de D,L-mentionina ou do seu sal
BR9810802B1 (pt)	2010-10-19	composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9711704A (pt)	1999-08-24	Composi-Æo de revestimento eletrodeposit vel contendo bismuto e materiais amino cidos e m-todo de eletrodeposi-Æo
BR9612465B1 (pt)	2010-08-10	compostos dipeptìdicos secretagogos do hormÈnio do crescimento.
BR9710447A (pt)	1999-08-17	Processo para prepara-Æo de microc psulas contendo material agricola ativo
PT91046A (pt)	1990-02-08	Processo para a preparacao de derivados alquilaminocarbonil-aminodiol de amino--acidos, uteis como agentes anti-hipertensivos
AU1735197A (en)	1997-09-10	Process for preparing free alpha-hydroxy acids from ammonium salts thereof
HUP0001674A3 (en)	2000-10-30	Process for the preparation of stable, non-hygroscopic salts of l(-)carnitine
BR9807988B1 (pt)	2013-06-18	processo para a preparaÇço de um composto, e, composto.
HU906967D0 (en)	1991-05-28	Fungicide preparatives containing new amino acid amine derivatives as active substance and process for producing the active substances
HUP0103754A3 (en)	2003-01-28	Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
AU6123699A (en)	2000-05-08	Nitrogenous fused heterocycle compounds, process for the preparation thereof andagents containing the same
BR8402999A (pt)	1985-05-28	Processo para preparacao de um composto de ureia,composicao herbicida e composicao algicida
AP9901486A0 (en)	1999-03-31	Process for preparing 2-azadihydroxybicyclo[2.2.1] heptane compounds and the l-tartaric acid salt of the compound
BR8804373A (pt)	1989-03-21	Compostos,processos para a preparacao de tais compostos,compostos intermediarios,composicao herbicida,processo para exterminacao de ervas daninhas prejudiciais e uso de um composto
DE3685662T2 (de)	1993-02-04	N-substituierte phenylteraconimidverbindung, herbizidzusammensetzung und verfahren zur kontrolle von unerwuenschtem unkraut.
NO934211L (no)	1994-05-25	Belagt titandioksyd, samt fremgangsmåte for fremstilling derav
BR8503377A (pt)	1986-04-08	Processo de inibicao de crescimento de vegetacao indesejada,composicao herbicida e processo para a preparacao de um composto
BR8804374A (pt)	1989-03-21	Compostos,processos para producao de compostos,compostos intermediarios,composicao herbicida,processo para controle do crescimento de ervas daninhas indesejaveis e uso de um composto
ZA200006081B (en)	2001-10-29	Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-A/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
BRPI0000967B1 (pt)	2012-06-12	processos para preparaÇço de compostos secretagogos de hormânio de crescimento.
BR8905978A (pt)	1990-06-19	Composto de amonia quaternaria oxialquilatada,processo de producao do referido composto e composicao reguladora do crescimento de planta
NO990675D0 (no)	1999-02-12	11-acetyl-12,13-dioksabisyklo[8.2.1.]-tridekenonderivater, fremgangsmÕter for deres fremstilling, samt legemidler inneholdende slike forbindelser
BR9703403B1 (pt)	2010-06-29	compostos, processo para preparação de compostos, utilização de composto e processo para preparação de composição farmacêutica.